Summary
Acute renal failure (ARF) is characterised by progressive azotaemia, and for therapeutic purposes consideration of prerenal, intrinsic renal and postrenal types still holds good.
Prerenal azotaemia is generally caused by loss of body fluids or blood, whereas postrenal azotaemia is effected by acute or chronic urinary tract obstruction. Provided these conditions are recognised on time and treated, they are reversible. However, delay in recognition or treatment could result in renal parenchymal damage and sustained ARF. Therefore utmost attention should be focused on identifying reversible factor(s) in the setting of ARF.
Once reversible factors have been excluded, and ARF becomes sustained, a diagnosis of acute intrinsic renal failure is almost certain. Lack of natriuretic and diuretic responses to fluid challenge or infusion of furosemide (frusemide) and dopamine are further indications of this possibility. Management of acute intrinsic renal failure essentially consists of dietary control and dialysis therapy. The latter facilitates fluid and electrolyte management, but does not reduce the overall mortality. The potential benefit of parenteral hyperalimentation to promote renal function recovery must be carefully weighed against the risk of severe infectious complications.
Similar content being viewed by others
References
Anderson RJ, Lings SL, Berns AS, Henrich WL, Miller TR, et al. Nonoliguric acute renal failure. New England Journal of Medicine 296: 1134–38, 1977
Aviado DM, Porter JM. Pentoxifylline, a new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy, and adverse effects. Pharmacotherapy 4: 297–307, 1984
Deconti RC, Calabresi P. Use of allopurinol and control of hyperuricemia in patients with neoplastic disease. New England Journal of Medicine 274: 481–486, 1966
Duarte RR. Acute renal failure. In Mandal AK & Jennette JC (Eds) Diagnosis and management of renal disease and hypertension, pp. 117–148, Lea & Febiger, Philadelphia, 1988
Finn WF. Diagnosis and management of acute tubular necrosis. Medical Clinics of North America 74: 873–891, 1990
Kassirer JP, Hricik DE, Cohen JJ. Repairing body fluids, pp. 1–26, WB Saunders & Co., Philadelphia, 1989
KleinKnecht D, Ganeval D, Gonzalez-Duque LA, Fermanian J. Furosemide in acute oliguria renal failure: a controlled trial. Nephron 17: 51–58, 1976
Lindner A, Cutler RE, Goodman WG. Synergism of dopamine plus furosemide in preventing acute renal failure in the dog. Kidney International 16: 158–166, 1979
Lindner A, Sherrad DJ, Shen F, Cutler RE. Dopamine and furosemide in acute renal failure. In Eliahou HE (Ed.) Acute renal failure, pp. 174–175, John Libbey, London, 1982
Mandal AK, Treat RC. Diagnosis and management of acute renal failure. Journal of Association Physicians India 32: 203–208, 1984
Mandal AK, Sklar AH, Hudson JB. Transmission electron microscopy of urinary sediment in human acute renal failure. Kidney International 28: 58–63, 1985
Mandal AK. Transmission electron microscopy of urinary sediment in renal disease. Seminars in Nephrology 6: 346–370, 1986
Mandal AK, Taylor CA, Bell RD, Hillman NM, Jarnot MD, et al. Erythrocyte deformation in ischemic acute tubular necrosis and amelioration by splenectomy in the dog. Laboratory Investigation 65: 566–576, 1991
Mazze RI, Shue GL, Jackson SH. Renal dysfunction associated with methoxyflurane anaesthesia. A randomized prospective evaluation. Journal of the American Medical Association 216: 278, 1971
Meyers AM, Hayward AR, Milne FJ. Role of total parenteral nutrition in reducing mortality of acute renal failure. In Eliahou HE (Ed.) Acute renal failure, pp. 190–193, John Libbey, London, 1982
Nahman NS, Middendorf DF. Continuous arteriovenous hemofiltration. Medical Clinics of North America 74: 975–984, 1990
Paller MS. Drug-induced nephropathies. Medical Clinics of North America 74: 909–917, 1990
Peterson CD. Ethylene glycol poisoning: pharmacokinetics during therapy with ethanol and hemodialysis. New England Journal of Medicine 304: 21, 1981
Olsen S. Renal histopathology in various forms of acute anuria in man. Kidney International 10 (Suppl.): 52–58, 1976
Solez K, Morel-Maroger L, Sraer JD. The morphology of ‚acute tubular necrosis, in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine 58: 362–376, 1979
Toback FG, Teegarden DE, Havener LJ. Amino-acid mediated stimulation of renal phospholipid biosynthesis after acute tubular necrosis. Kidney International 15: 542–547, 1979
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mandal, A.K., Visweswaran, R.K. & Kaldas, N.R. Treatment Considerations in Acute Renal Failure. Drugs 44, 567–577 (1992). https://doi.org/10.2165/00003495-199244040-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199244040-00004